Skip to content

TO STUDY THE THE EFFECT OF MUSTAKATUKA CHURNA IN RASIED LIPID LEVELS

CONTROLLED STUDY OF MUSTAKATUKA CHURNA IN RASA RAKTAGAT MEDO DUSHTI W.S.R. TO DYSLIPIDEMIA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040171
Enrollment
60
Registered
2022-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E788- Other disorders of lipoprotein metabolism

Interventions

None listed

Sponsors

Dr Akanksha Dandekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: newly diagnosed dyslipidemia patients Lipid Panel: SR. NO. LIPID PANEL BORDERLINE 1 Total Cholesterol 200 to 293 mg/dl 2 LDL-C 130 to 159 mg /dl 3 HDL-C 35 to 45 mg/dl 4 Triglycerides 150-199 mg/dl

Exclusion criteria

Exclusion criteria: Age: 75yrs Pregnant women & lactating mothers. Patients having history of serious cardiac disorders like myocardial infarction, cardiac failure, COPD. Untreated thyroid disorder. Patients having any major illness like uncontrolled diabetes mellitus. Known case of Asthma, neurological disorders, anemia (Hb Known case of Renal insufficiency, nephrotic syndrome. Known case of severe Liver diseases. Known case of HIV positive and HbsAg positive patients. Immune compromised patients. Any serious medical and psychological condition subjects will not be included. Blood Lipid profile according to NCEP -According to Adult Treatment Panel SR. NO. LIPID PANEL DESIRABLE HIGH RISK 1 Total Cholesterol 240 mg/dl 2 LDL-C > 130mg/dl 160-189 mg/dl 3 HDL-C - Male - Female 4 Triglycerides >150 mg/dl 200-499 mg/dl

Design outcomes

Primary

MeasureTime frame
Controlled study of MustaKatuka churna in rasa raktagat medo dushti w.s.r. to DyslipidemiaTimepoint: 0 to 45 days

Secondary

MeasureTime frame
To study the efficacy of mustakatuka churna in management of dyslipidemia To study the effects of Atorvastatin To compare the results of both groupsTimepoint: 0 to 45 days

Countries

India

Contacts

Public ContactDr Kalpana Satpute

School of Ayurveda, Dr.D.Y.Patil deemed to be University

dr.akankshadandekar@gmail.com9637998998

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026